APA (7th ed.) Citation

Itzykson, R., Thépot, S., Beyne-Rauzy, O., Ame, S., Isnard, F., Dreyfus, F., . . . Fenaux, P. (2012). Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine? Leukemia Research, 36(4), 397. https://doi.org/10.1016/j.leukres.2011.11.019

Chicago Style (17th ed.) Citation

Itzykson, R., et al. "Does Addition of Erythropoiesis Stimulating Agents Improve the Outcome of Higher-risk Myelodysplastic Syndromes Treated with Azacitidine?" Leukemia Research 36, no. 4 (2012): 397. https://doi.org/10.1016/j.leukres.2011.11.019.

MLA (9th ed.) Citation

Itzykson, R., et al. "Does Addition of Erythropoiesis Stimulating Agents Improve the Outcome of Higher-risk Myelodysplastic Syndromes Treated with Azacitidine?" Leukemia Research, vol. 36, no. 4, 2012, p. 397, https://doi.org/10.1016/j.leukres.2011.11.019.